Pine Labs Share Price Today (PINELABS)
TODAY IN ONE LINE
PINELABS fell 1.1% on light volume, lagging Nifty's -0.0% move, supported by recent strong earnings.
With a market cap of ₹17,890.15 Cr., it trades at a P/E of 160.41. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
Pine Labs flags
Key strengths and potential risks.
Green Flags
- ●Quarterly OutperformanceLatest quarter Sales up 17.0% and Profit up 284.0%
- ●Virtually Debt-FreeVery low Debt-to-Equity of 0.00x
Red Flags
- ●Poor Capital ReturnsLow ROE of 2.5%
- ●Expensive ValuationTrading at a high P/E ratio of 158.7x
- ●Promoter Pledging DetectedPledge activity recorded on 16-Dec-2025 16:13
What changed recently?
Recent events, corporate actions, and announcements.
Pine Labs Limited valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for Pine Labs Limited, framed against the sector median so the premium or discount is obvious at a glance.
Pine Labs Limited trades at a P/E of 160.41× and P/B of 3.06×.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
Pine Labs Limited technical analysis: indicators, pivots and CPR.
Live RSI, MACD and moving-average signals plus today's pivot and Central Pivot Range levels for Pine Labs Limited — derived from the live tape, not yesterday's close.
Pine Labs Limited last traded at ₹155.56 with an intraday range of ₹155.1–₹159.49 — live indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Live: ₹155.56| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 167.11 | +11.55 | +7.43% |
| R3 | 162.72 | +7.16 | +4.60% |
| R2 | 161.11 | +5.55 | +3.57% |
| R1 | 158.33 | +2.77 | +1.78% |
| PIVOT | 156.72 | 1.16 | 0.74% |
| CURRENT | 155.56 | — | — |
| S1 | 153.94 | -1.62 | -1.04% |
| S2 | 152.33 | -3.23 | -2.08% |
| S3 | 149.55 | -6.01 | -3.86% |
| S4 | 145.16 | -10.40 | -6.68% |
PINELABS is trading Below CPR, indicating Bearishness
CPR is Wider, suggesting unlikely for trending moves
Day's range: ₹157.78–₹159.33
Trading Below opening range, showing Bearishness
Pine Labs Limited financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for Pine Labs Limited — consolidated or standalone — with margins, YoY growth and key ratios inline.
Pine Labs Limited reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹17,890.15 Cr. and reported EPS of ₹1.03.
| Metric | — | Mar 2026 |
|---|---|---|
| Revenue from Operations | — | 2,711 |
| Other Income | — | 137 |
| Total Income | — | 2,847 |
| — | 366 | |
| Gross ProfitDerived | — | 2,344 |
| Gross Margin %Derived | — | 86.48% |
| — | 1,986 | |
| EBITDA (Operating Profit)Derived | — | 358 |
| OPM %Derived | — | 13.23% |
| — | 351 | |
| Profit Before Tax (PBT) | — | 137 |
| — | 25 | |
| Effective Tax %Derived | — | 18.02% |
| Total Profit for Period | — | 113 |
| Net Profit (Owner's PAT)Derived | — | 113 |
| Net Profit Margin %Derived | — | 4.15% |
| Earnings Per Share (EPS ₹) | — | 0.98 |
| Diluted Shares Outstanding (Cr) | — | 115 |
| Share of Profit from Associates/JVs | — | -0 |
| Other Comprehensive Income (Net of Tax) | — | 14 |
| Total Expenses (incl. D&A & Interest) | — | 2,710 |
| Material Cost % of RevenueDerived | — | — |
| Employee Cost % of RevenueDerived | — | 39.44% |
| Other Cost % of RevenueDerived | — | 33.82% |
| Interest Coverage (x)Derived | — | 1.05x |
| Period | Mar 2026 | Trend |
|---|---|---|
| Revenue from Operations | 2,711 | |
| Other Income | 137 | |
| Total Income | 2,847 | |
366 | ||
| Gross ProfitDerived | 2,344 | |
| Gross Margin %Derived | 86.48% | |
1,986 | ||
| EBITDA (Operating Profit)Derived | 358 | |
| OPM %Derived | 13.23% | |
351 | ||
| Profit Before Tax (PBT) | 137 | |
25 | ||
| Effective Tax %Derived | 18.02% | |
| Total Profit for Period | 113 | |
| Net Profit (Owner's PAT)Derived | 113 | |
| Net Profit Margin %Derived | 4.15% | |
| Earnings Per Share (EPS ₹) | 0.98 | |
| Diluted Shares Outstanding (Cr) | 115 | |
| Share of Profit from Associates/JVs | -0 | |
| Other Comprehensive Income (Net of Tax) | 14 | |
| Total Expenses (incl. D&A & Interest) | 2,710 | |
| Material Cost % of RevenueDerived | — | |
| Employee Cost % of RevenueDerived | 39.44% | |
| Other Cost % of RevenueDerived | 33.82% | |
| Interest Coverage (x)Derived | 1.05x |
Pine Labs segment analysis : revenue and profit mix.
Disclosed business segments at Pine Labs with their share of revenue and profit, switchable between consolidated and standalone reporting.
Pine Labs discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for Pine Labs Limited.
Our AI distills the core fundamental drivers supporting Pine Labs Limited, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
Pine Labs Limited's investment case rests on 10 positive markers and 10 flagged concerns drawn from the latest reported filings.
What you're getting.
Operating cash flow ₹490 Cr exceeds net profit ₹150 Cr, demonstrating strong cash conversion quality.
Fortress balance sheet. net debt negative ₹1,001 Cr with D/E 0.0007x, minimal financial leverage.
Institutional ownership 48.53% signals moderate professional investor confidence in fintech platform.
Multi-brand portfolio (Pinelabs, Mosambee, Benow, Setu, Qfix, Fave) provides diversified merchant reach.
Current ratio 1.49x with ₹1,252 Cr cash ensures adequate liquidity for operational needs.
Key Risks.
P/E ratio 158.66x far exceeds fintech sector median, indicating severe overvaluation without earnings justification.
TTM revenue declined 34.3% YoY, signaling significant business contraction and demand destruction.
ROE 2.46% and ROCE 4.16% critically underperform sector benchmarks, indicating capital inefficiency.
Net margin 3.03% TTM reveals 77% margin leakage from operations to bottom line via finance costs.
Free cash flow approximately negative ₹1,045 Cr; capex ₹1,535 Cr unsustainable without external financing.
Flip Conditions.
Valuation risk. a P/E above 209 would leave less room for earnings disappointment.
Fundamental risk. a shrinking deal pipeline (TCV) or margins below historical averages would weaken the thesis.
Watch wage inflation and attrition rates — primary threats to operating leverage in IT.
Return-quality risk. ROE below 8% would indicate weaker capital compounding.
Pine Labs Limited peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — Pine Labs Limited is highlighted for quick read-across.
Quick Compare
Peer Comparison
| Company Name |
|---|
Pine Labs Limited chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for Pine Labs Limited — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
- 1Pick how to scan. Detection sets sensitivity — Daily (standard) → Weekly (big swings). History sets how far back to look.
- 2Read the summary. The tiles at the top give the current read: net bias, the strongest pattern, and the one nearest to triggering.
- 3Scan the list. Use the Actionable, Watchlist, and History tabs to browse patterns. Click a pattern card to focus it.
- 4Inspect on the chart. Focusing draws the pattern’s pivots plus its break (blue), target (amber) and invalidation lines.
- 5Filter to what matters. Use the status controls (Confirmed, Forming, Invalidated) to hide noise and find exactly what you are looking for.
Pattern history — every completed pattern and its outcome
Pine Labs Limited delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for Pine Labs Limited over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in Pine Labs Limited stood at 41.1% of traded volume, against a 20-day average of 40.4%.
Pine Labs announcements: results, concalls, ratings, M&A.
Filings Pine Labs sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
Pine Labs files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 65 documents below.
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Pine Labs Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Acquisition
Pine Labs Limited has informed the Exchange about Acquisition
Analysts/Institutional Investor Meet/Con. Call Updates
Pine Labs Limited has informed the Exchange about Schedule of meet
Trading Window
Pine Labs Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Rumour Verification - Regulation 30(11)
Pine Labs Limited has informed the Exchange about Rumour Verification - Regulation 30(11)
Investor decks & rating reports.
Pine Labs dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue Pine Labs has declared, sequenced by announce and record date.
Pine Labs corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About Pine Labs Limited: business, sector, key facts.
What Pine Labs Limited does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
Pine Labs Limited operates in the Financial Technology (Fintech) industry under the Financial Services sector.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- Authum Investment & Infrastructure (AIIL) Share PricePeer
- AKCapital Services (AKCAPIT) Share PricePeer
- Algoquant Fintech (ALGOQUANT) Share PricePeer
- Anand Rathi Share and Stock Brokers (ARSSBL) Share PricePeer
- Ashika Credit Capital (ASHIKA) Share PricePeer
- Other overvalued NSE stocksScreener
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about Pine Labs Limited (PINELABS).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of Pine Labs Limited (PINELABS)?
The current share price of Pine Labs Limited (PINELABS) is ₹155.56. Today, the stock has declined by ₹1.69 (1.07%), trading in a range of ₹155.1 to ₹159.49. The stock opened at ₹158.5 with a trading volume of 1,01,38,739 shares.
02Is Pine Labs Limited stock a good investment for long-term?
Pine Labs Limited can be considered for long-term investment based on several factors. The company has a market capitalization of ₹17,890.15 crores, P/E ratio of 160.41, ROE of 2.46%, and ROCE of 4.16%. The dividend yield stands at 0.00%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of Pine Labs Limited stock?
The 52-week high price of Pine Labs Limited (PINELABS) is ₹284, while the 52-week low is ₹134.73. Currently trading at ₹155.56, the stock is 14.0% away from its 52-week low and 45.2% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy Pine Labs Limited stock at the current price?
Whether to buy Pine Labs Limited stock at ₹155.56 depends on multiple factors. The stock is currently trading with a P/E ratio of 160.41 and P/B ratio of 3.06. Today's performance shows a loss of 1.07%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of Pine Labs Limited and when is the next dividend?
Pine Labs Limited offers a dividend yield of 0.00%, which means for every ₹100 invested at the current price of ₹155.56, you can expect to receive approximately ₹0.00 annually as dividends. The face value of the stock is ₹1.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of Pine Labs Limited?
Pine Labs Limited's key financial metrics include: P/E Ratio: 160.41, P/B Ratio: 3.06, ROE: 2.46%, ROCE: 4.16%, Dividend Yield: 0.00%, EPS: ₹1.03, Book Value: ₹51.64, and Debt-to-Equity: 0.07. The company's market cap stands at ₹17,890.15 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is Pine Labs Limited stock performing today in the market?
Pine Labs Limited stock opened at ₹158.5 and is currently trading at ₹155.56, showing a decline of ₹1.69 (1.07%). The intraday high is ₹159.49 and low is ₹155.1. The trading volume stands at 1,01,38,739 shares, indicating strong market participation today.
08What is the P/E ratio of Pine Labs Limited and what does it indicate?
Pine Labs Limited has a Price-to-Earnings (P/E) ratio of 160.41, which means investors are willing to pay ₹160.41 for every ₹1 of earnings. With an EPS of ₹1.03, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about Pine Labs Limited (PINELABS) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.